Table 4 Distribution of causes of drug-related problems (DRPs) per anatomical therapeutic chemical (ATC) group. Numbers in bold are the highest values in each column
Drug selection (C1) | Dose selection (C3) | Treatment duration (C4) | Patient related (C7) | Other causes (C8) a | |||||
|---|---|---|---|---|---|---|---|---|---|
Inappropriate drug according to guidelines (C1.1) | Contra-indicated (C1.2) | No indication for drug (C1.3) | No treatment for indication (C1.6) | Too many drugs for indication (C1.7) | |||||
n = 62 | n = 71 | n = 139 | n = 75 | n = 35 | n = 97 | n = 31 | n = 5 | n = 21 | |
ATC group | |||||||||
Alimentary tract and metabolism (ATC group A) | 3 | 6 | 82 | 28 | 22 | 1 | 1 | 1 | |
Blood and blood-forming organs (ATC group B) | 1 | 4 | 8 | 6 | 11 | 7 | 1 | ||
Cardiovascular system (ATC group C) | 6 | 35 | 25 | 3 | 32 | 17 | 1 | 7 | |
Genitourinary system and reproductive hormones (ATC group G) | 2 | 13 | 1 | ||||||
Systemic hormonal preparations excluding reproductive hormones and insulin (ATC group H) | 1 | 1 | 5 | 1 | |||||
Anti-infective agents for systemic use (ATC group J) | 1 | 2 | 2 | 1 | 2 | 2 | |||
Antineoplastic and immunomodulating agents (ATC group L) | 1 | 2 | 1 | 1 | |||||
Musculoskeletal system (ATC group M) | 3 | 11 | 2 | 20 | 1 | 2 | |||
Nervous system (ATC group N) | 41 | 8 | 9 | 8 | 1 | 33 | 1 | 6 | |
Respiratory system (ATC group R) | 3 | 5 | 2 | 7 | 2 | ||||
Various (ATC group V) | 4 | 1 | 3 | 2 | 2 | 4 | 4 | 1 | 3 |